​

Cassava Sciences (SAVA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

SAVA Stock Rating

Cassava Sciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

SAVA Price Target Upside V Benchmarks

TypeNameUpside
StockCassava Sciences-
SectorHealthcare Stocks 25.19%
IndustryBiotech Stocks 61.26%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.78$2.78$2.78
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25--2--2
Jan, 25--2--2
Dec, 241-2--3
Nov, 241-2--3
Oct, 241-2--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 08, 2024Wells FargoBuyupgrade
Oct 08, 2024H.C. WainwrightNeutralBuyupgrade
Jul 19, 2024H.C. WainwrightNeutralNeutralhold
Jul 01, 2024H.C. WainwrightBuyNeutraldowngrade
May 17, 2024H.C. WainwrightBuyBuyhold
Nov 24, 2022B. Riley SecuritiesBuyNeutraldowngrade
Aug 11, 2022B. Riley SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.32-----
Avg Forecast$-2.34$-0.86$-0.44$0.10$0.09$0.10
High Forecast$-2.34$-0.86$-0.44$0.10$0.09$0.10
Low Forecast$-2.34$-0.86$-0.44$0.10$0.09$0.10
Surprise %-0.85%-----

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$100.00M$50.00M-$2.10M$72.40M
High Forecast-$100.00M$50.00M-$2.10M$72.40M
Low Forecast-$100.00M$50.00M-$2.10M$72.40M
Surprise %------

Net Income Forecast

$-100M $-70M $-40M $-10M $20M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-97.22M-----
Avg Forecast$-98.12M$-36.20M$-18.24M$4.19M$3.77M$4.19M
High Forecast$-98.12M$-36.20M$-18.24M$4.19M$3.77M$4.19M
Low Forecast$-98.12M$-36.20M$-18.24M$4.19M$3.77M$4.19M
Surprise %-0.92%-----

SAVA Forecast FAQ

Is Cassava Sciences stock a buy?

Cassava Sciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cassava Sciences is a favorable investment for most analysts.

What is Cassava Sciences's price target?

Cassava Sciences's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.78.

How does Cassava Sciences stock forecast compare to its benchmarks?

Cassava Sciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.19%) and underperforming the biotech stocks industry (61.26%).

What is the breakdown of analyst ratings for Cassava Sciences over the past three months?

  • February 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Cassava Sciences’s EPS forecast?

Cassava Sciences's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.86, marking a -62.93% decrease from the reported $-2.32 in 2023. Estimates for the following years are $-0.44 in 2025, $0.1 in 2026, $0.09 in 2027, and $0.1 in 2028.

What is Cassava Sciences’s revenue forecast?

Cassava Sciences's average annual revenue forecast for its fiscal year ending in December 2024 is $100M, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $50M, followed by $0 for 2026, $2.1M for 2027, and $72.4M for 2028.

What is Cassava Sciences’s net income forecast?

Cassava Sciences's net income forecast for the fiscal year ending in December 2024 stands at $-36.201M, representing a -62.76% decrease from the reported $-97.217M in 2023. Projections indicate $-18.24M in 2025, $4.19M in 2026, $3.77M in 2027, and $4.19M in 2028.